| Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer (NCT07765433) | ECOG-ACRIN Cancer Research Group | 2027-01-11 |
| Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity (NCT07001748) | ECOG-ACRIN Cancer Research Group | 2025-08-19 |
| Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma (NCT06526897) | ECOG-ACRIN Cancer Research Group | 2025-01-28 |
| Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer (NCT06475989) | ECOG-ACRIN Cancer Research Group | 2024-08-22 |
| Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer (NCT06084845) | ECOG-ACRIN Cancer Research Group | 2024-04-12 |
| Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial (NCT06319027) | ECOG-ACRIN Cancer Research Group | 2024-04-11 |
| Mobile Health for Adherence in Breast Cancer Patients (NCT06112613) | ECOG-ACRIN Cancer Research Group | 2024-04-02 |
| Cost Communication and Financial Navigation in Cancer Patients (COSTCOM) (NCT06295367) | ECOG-ACRIN Cancer Research Group | 2024-02-29 |
| Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial (NCT05863195) | ECOG-ACRIN Cancer Research Group | 2023-10-19 |
| Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors (NCT06002828) | ECOG-ACRIN Cancer Research Group | 2023-10-13 |
| Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study (NCT05863351) | ECOG-ACRIN Cancer Research Group | 2023-09-07 |
| Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT05721755) | ECOG-ACRIN Cancer Research Group | 2023-06-08 |
| Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial (NCT05710328) | ECOG-ACRIN Cancer Research Group | 2023-05-10 |
| Intravesical BCG vs GEMDOCE in NMIBC (NCT05538663) | ECOG-ACRIN Cancer Research Group | 2023-02-07 |
| Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials (NCT05108298) | ECOG-ACRIN Cancer Research Group | 2021-11-10 |
| To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring (NCT04597359) | ECOG-ACRIN Cancer Research Group | 2021-10-05 |
| Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement (NCT04221438) | ECOG-ACRIN Cancer Research Group | 2021-09-22 |
| Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma (NCT04527549) | ECOG-ACRIN Cancer Research Group | 2021-06-01 |
| Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study (NCT04484818) | ECOG-ACRIN Cancer Research Group | 2021-03-01 |
| Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer (NCT04559139) | ECOG-ACRIN Cancer Research Group | 2021-02-24 |
| Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial (NCT04566328) | ECOG-ACRIN Cancer Research Group | 2021-02-24 |
| Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial (NCT04462406) | ECOG-ACRIN Cancer Research Group | 2021-02-09 |
| Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis (NCT04438382) | ECOG-ACRIN Cancer Research Group | 2021-01-07 |
| Cancer and Blood Pressure Management, CARISMA Study (NCT04467021) | ECOG-ACRIN Cancer Research Group | 2020-10-29 |
| Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging (NCT04423211) | ECOG-ACRIN Cancer Research Group | 2020-10-08 |
| Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study (NCT04316117) | ECOG-ACRIN Cancer Research Group | 2020-09-15 |
| Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread (NCT04233866) | ECOG-ACRIN Cancer Research Group | 2020-08-26 |
| Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers (NCT04239573) | ECOG-ACRIN Cancer Research Group | 2020-06-16 |
| Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body (NCT04248452) | ECOG-ACRIN Cancer Research Group | 2020-05-26 |
| CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy (NCT04266249) | ECOG-ACRIN Cancer Research Group | 2020-03-13 |
| Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study (NCT04166318) | ECOG-ACRIN Cancer Research Group | 2020-01-02 |
| A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT04115631) | ECOG-ACRIN Cancer Research Group | 2019-12-13 |
| Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma (NCT03937635) | ECOG-ACRIN Cancer Research Group | 2019-09-16 |
| Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer (NCT04001829) | ECOG-ACRIN Cancer Research Group | 2019-08-09 |
| Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices (NCT03808818) | ECOG-ACRIN Cancer Research Group | 2019-08-01 |
| Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease (NCT03516279) | ECOG-ACRIN Cancer Research Group | 2019-06-26 |
| Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery (NCT03493425) | ECOG-ACRIN Cancer Research Group | 2019-03-12 |
| Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer (NCT03697148) | ECOG-ACRIN Cancer Research Group | 2019-02-11 |
| Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting (NCT03804255) | ECOG-ACRIN Cancer Research Group | 2019-01-08 |
| Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab (NCT03412630) | ECOG-ACRIN Cancer Research Group | 2018-12-13 |
| Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia (NCT03504644) | ECOG-ACRIN Cancer Research Group | 2018-08-13 |
| Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment (NCT03516942) | ECOG-ACRIN Cancer Research Group | 2018-06-11 |
| Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel (NCT03419234) | ECOG-ACRIN Cancer Research Group | 2018-04-26 |
| Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission (NCT03267433) | ECOG-ACRIN Cancer Research Group | 2017-11-27 |
| Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer (NCT03233191) | ECOG-ACRIN Cancer Research Group | 2017-09-28 |
| Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia (NCT03253848) | ECOG-ACRIN Cancer Research Group | 2017-09-26 |
| DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma (NCT03115333) | ECOG-ACRIN Cancer Research Group | 2017-07-25 |
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts (NCT02933489) | ECOG-ACRIN Cancer Research Group | 2016-12-27 |
| Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery (NCT02734537) | ECOG-ACRIN Cancer Research Group | 2016-11-23 |
| Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer (NCT02823652) | ECOG-ACRIN Cancer Research Group | 2016-10-25 |
| Reproductive Health Program in Patients With Cancer (NCT01806129) | ECOG-ACRIN Cancer Research Group | 2016-09-02 |
| Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer (NCT02560298) | ECOG-ACRIN Cancer Research Group | 2016-08-23 |
| Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery (NCT02607423) | ECOG-ACRIN Cancer Research Group | 2015-11-19 |
| Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas (NCT02595424) | ECOG-ACRIN Cancer Research Group | 2015-11-06 |
| Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy (NCT02445391) | ECOG-ACRIN Cancer Research Group | 2015-10-20 |
| Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer (NCT02412670) | ECOG-ACRIN Cancer Research Group | 2015-08-27 |
| MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ (NCT02352883) | ECOG-ACRIN Cancer Research Group | 2015-03-25 |
| Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) (NCT02201992) | ECOG-ACRIN Cancer Research Group | 2015-03-23 |
| Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence (NCT01824823) | ECOG-ACRIN Cancer Research Group | 2014-06-30 |
| Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery (NCT02031536) | ECOG-ACRIN Cancer Research Group | 2014-04-10 |
| Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer (NCT01898494) | ECOG-ACRIN Cancer Research Group | 2014-01-22 |
| Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer (NCT01824901) | ECOG-ACRIN Cancer Research Group | 2014-01-15 |
| Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT01863550) | ECOG-ACRIN Cancer Research Group | 2013-12-06 |
| Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors (NCT01824875) | ECOG-ACRIN Cancer Research Group | 2013-08-08 |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) (NCT01824836) | ECOG-ACRIN Cancer Research Group | 2013-06-11 |
| Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma (NCT01390584) | ECOG-ACRIN Cancer Research Group | 2013-05-24 |
| Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 (NCT00899873) | ECOG-ACRIN Cancer Research Group | 2012-04-17 |
| Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma (NCT01381705) | ECOG-ACRIN Cancer Research Group | 2012-02-06 |
| Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate (NCT01209299) | ECOG-ACRIN Cancer Research Group | 2012-01-19 |
| Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial (NCT01505712) | ECOG-ACRIN Cancer Research Group | 2011-12-15 |
| Biomarkers in Patients With Head and Neck Cancer (NCT01466257) | ECOG-ACRIN Cancer Research Group | 2011-11-21 |
| Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia (NCT01013961) | ECOG-ACRIN Cancer Research Group | 2011-04-27 |
| Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab (NCT01156168) | ECOG-ACRIN Cancer Research Group | 2011-04-05 |
| Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma (NCT01216683) | ECOG-ACRIN Cancer Research Group | 2011-02-09 |
| Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690 (NCT00937781) | ECOG-ACRIN Cancer Research Group | 2011-02-08 |
| Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT02085408) | ECOG-ACRIN Cancer Research Group | 2011-02-04 |
| BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT00828009) | ECOG-ACRIN Cancer Research Group | 2011-01-17 |
| Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer (NCT01124695) | ECOG-ACRIN Cancer Research Group | 2011-01-07 |
| Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NCT01107626) | ECOG-ACRIN Cancer Research Group | 2010-10-25 |
| Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery (NCT01164228) | ECOG-ACRIN Cancer Research Group | 2010-09-17 |
| Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy (NCT01194635) | ECOG-ACRIN Cancer Research Group | 2010-08-05 |
| Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab (NCT01192750) | ECOG-ACRIN Cancer Research Group | 2010-08-05 |
| Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy (NCT01169363) | ECOG-ACRIN Cancer Research Group | 2010-07-08 |
| Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate (NCT01124669) | ECOG-ACRIN Cancer Research Group | 2010-06-13 |
| Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab (NCT01131208) | ECOG-ACRIN Cancer Research Group | 2010-04-21 |
| Biomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With Erlotinib Hydrochloride (NCT01123460) | ECOG-ACRIN Cancer Research Group | 2010-04-12 |
| Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ (NCT01132560) | ECOG-ACRIN Cancer Research Group | 2010-03-05 |
| Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia (NCT01251159) | ECOG-ACRIN Cancer Research Group | 2009-05-15 |
| Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 (NCT00897351) | ECOG-ACRIN Cancer Research Group | 2008-07-10 |
| Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00898911) | ECOG-ACRIN Cancer Research Group | 2008-07-08 |
| Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer (NCT00897845) | ECOG-ACRIN Cancer Research Group | 2008-06-17 |
| Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel (NCT00900172) | ECOG-ACRIN Cancer Research Group | 2008-03-15 |
| Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab (NCT00898417) | ECOG-ACRIN Cancer Research Group | 2008-03-14 |
| Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy (NCT00897520) | ECOG-ACRIN Cancer Research Group | 2008-01-14 |
| Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia (NCT00898261) | ECOG-ACRIN Cancer Research Group | 2007-10-26 |
| Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494 (NCT00898157) | ECOG-ACRIN Cancer Research Group | 2007-09-24 |
| Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab (NCT00897754) | ECOG-ACRIN Cancer Research Group | 2007-07-24 |
| Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma (NCT00897546) | ECOG-ACRIN Cancer Research Group | 2007-06-01 |
| Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery (NCT00898495) | ECOG-ACRIN Cancer Research Group | 2007-05-11 |
| Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496 (NCT00898963) | ECOG-ACRIN Cancer Research Group | 2007-04-18 |